Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMprove PAtient Compliance sTudy: An Observational, Cross-sectional Study on Children Treated With Growth Hormone in France

NCT01068639 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01068639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01068639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMprove PAtient Compliance sTudy: An Observational, Cross-sectional Study on Children Treated With Growth Hormone in France
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Withdrawn
Start date
February 28, 2010
Completion date
April 30, 2010
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

growth hormone deficiency in children, growth hormone disorder